Harnessing the Therapeutic Potential of Th17 Cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Bystrom, Jonas ^a   Taher, Taher E ^a   Muhyaddin, M Sherwan ^b   Clanchy, Felix I ^c   Mangat, Pamela ^d   Jawad, Ali S ^e   Williams, Richard O ^c   Mageed, Rizgar A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b HAWLER MEDICAL UNIVERSITY   (Iraq)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; T LYMPHOCYTE RECEPTOR; GAMMA INTERFERON;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; INTRACELLULAR SIGNALING; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; REVIEW; TH17 CELL; TUMOR MICROENVIRONMENT; VACCINATION; AUTOIMMUNE DISEASES; BIOSYNTHESIS; CELL PLASTICITY; IMMUNOLOGY; MYCOBACTERIUM TUBERCULOSIS; NEOPLASMS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

FUNGI;

AUTOIMMUNE DISEASES; CELL PLASTICITY; HUMANS; INTERFERON-GAMMA; MYCOBACTERIUM TUBERCULOSIS; NEOPLASMS; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE; TH17 CELLS; VACCINATION;

EID: 84935839982     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/205156     Document Type: Review

References (102)

1. F. Broere, S. G. Apasov, M. V. Sitkovsky, and W. van Eden, "T cell subsets and T cell mediated immunity, " in Principles of Immunopharmacology, F. P. Nijkamp and M. J. Parnham, Eds., Birkhauser, Basel, Switzerland, 2011.
2. C. Sutton, C. Brereton, B. Keogh, K. H. G. Mills, and E. C. Lavelle, "A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis, " The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1685-1691, 2006.
3. P. Guo, M. Hirano, B. R. Herrin, et al., "Dual nature of the adaptive immune system in lampreys, " Nature, vol. 459, no. 7248, pp. 796-801, 2009.
4. M. H. Shaw, N. Kamada, Y.-G. Kim, and G. Nunez, "Microbiotainduced IL-1β, but not IL-6, is critical for the development of steady-state Tβ17 cells in the intestine, " Journal of Experimental Medicine, vol. 209, no. 2, pp. 251-258, 2012.
5. W. Ouyang, J. K. Kolls, and Y. Zheng, "The biological functions of T helper 17 cell effector cytokines in inflammation, " Immunity, vol. 28, no. 4, pp. 454-467, 2008.
6. Y. Zheng, P. A. Valdez, D. M. Danilenko, et al., "Interleukin mediates early host defense against attaching and effacing bacterial pathogens, " Nature Medicine, vol. 14, no. 3, pp. 282-289, 2008.
7. M. Mitsdoerffer, Y. Lee, A. Jager, et al., "Proinflammatory T helper type 17 cells are effective B-cell helpers, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 32, pp. 14292-14297, 2010.
8. S. L. Gaffen, "Structure and signalling in the IL-17 receptor family, " Nature Reviews Immunology, vol. 9, no. 8, pp. 556-567, 2009.
9. C. Y. Kao, Y. Chen, P. Thai, et al., "IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways, " Journal of Immunology, vol. 173, no. 5, pp. 3482-3491, 2004.
10. C. A. Hitchon, P. Alex, L. B. Erdile, et al., "A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis, "The Journal of Rheumatology, vol. 31, no. 12, pp. 2336-2346, 2004.
11. S. A. Khader, G. K. Bell, J. E. Pearl, et al., "IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge, " Nature Immunology, vol. 8, no. 4, pp. 369-377, 2007.
12. T. Yago, Y. Nanke, N. Ichikawa, et al., "IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17, " Journal of Cellular Biochemistry, vol. 108, no. 4, pp. 947-955, 2009.
13. H. Fujie, K. Niu, M. Ohba, et al., "A distinct regulatory role of Th17 cytokines IL-17A and IL-17F in chemokine secretion from lung microvascular endothelial cells, " Inflammation, vol. 35, no. 3, pp. 1119-1131, 2012.
14. I. Kryczek, E. Zhao, Y. Liu, et al., "Human TH17 cells are longlived effector memory cells, " Science TranslationalMedicine, vol. 3, no. 104, Article ID 104ra100, 2011.
15. C. E. Zielinski, F. Mele, D. Aschenbrenner, et al., "Pathogeninduced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta, " Nature, vol. 484, no. 7395, pp. 514-518, 2012.
16. L. Cosmi, R. De Palma, V. Santarlasci, et al., "Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor, " The Journal of Experimental Medicine, vol. 205, no. 8, pp. 1903-1916, 2008.
17. R. Ramesh, L. Kozhaya, K. McKevitt, et al., "Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids, " The Journal of Experimental Medicine, vol. 211, no. 1, pp. 89-104, 2014.
18. P. Muranski, Z. A. Borman, S. P. Kerkar, et al., "Th17 cells are long lived and retain a stemcell-like molecular signature, " Immunity, vol. 35, no. 6, pp. 972-985, 2011.
19. C. Leonardi, R. Matheson, C. Zachariae, et al., "Anti-interleukin monoclonal antibody ixekizumab in chronic plaque psoriasis, " The New England Journal of Medicine, vol. 366, no. 13, pp. 1190-1191, 2012.
20. K. A. Papp, C. Leonardi, A. Menter, et al., "Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis, " The New England Journal ofMedicine, vol. 366, no. 13, pp. 1181-1189, 2012.
21. I. B. McInnes, J. Sieper, J. Braun, et al., "Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, rand omised, double-blind, placebo-controlled, phase II proof-of-concept trial, " Annals of the Rheumatic Diseases, vol. 73, no. 2, pp. 349-356, 2014.
22. M. C. Genovese, M. Greenwald, C. Cho, et al., "A phase II rand omized study of subcutaneous ixekizumab, an antiinterleukin monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors, " Arthritis & Rheumatology, vol. 66, no. 7, pp. 1693-1704, 2014.
23. D. Baeten, X. Baraliakos, J. Braun, et al., "Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a rand omised, double-blind, placebo-controlled trial, " The Lancet, vol. 382, no. 9906, pp. 1705-1713, 2013.
24. W. Hueber, B. E. Sands, S. Lewitzky, et al., "Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohns disease: unexpected results of a rand omised, double-blindplacebo-controlled trial, " Gut, vol. 61, no. 12, pp. 1693-1700, 2012.
25. K. Hirota, J. H. Duarte, M. Veldhoen, et al., "Fate mapping of IL-17-producing T cells in inflammatory responses, " Nature Immunology, vol. 12, no. 3, pp. 255-263, 2011.
26. Y. Lee, A. Awasthi, N. Yosef, et al., "Induction and molecular signature of pathogenic TH17 cells, " Nature Immunology, vol. 13, no. 10, pp. 991-999, 2012.
27. Z. Deng, J. Mu, M. Tseng, et al., "Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to driveTh17-mediated tumorigenesis, " Nature Communications, vol. 6, article 6956, 2015.
28. M. Ciofani, A. Madar, C. Galan, et al., "A validated regulatory network for Th17 cell specification, " Cell, vol. 151, no. 2, pp. 289-303, 2012.
29. B. U. Schraml, K. Hildner, W. Ise, et al., "The AP-1 transcription factor Batf controls TH17 differentiation, " Nature, vol. 460, no. 7253, pp. 405-409, 2009.
30. H. A. Purvis, J. N. Stoop, J. Mann, et al., "Low-strength T-cell activation promotes Th17 responses, " Blood, vol. 116, no. 23, pp. 4829-4837, 2010.
31. Y. Chung, S. H. Chang, G. J. Martinez, et al., "Critical regulation of early Th17 cell differentiation by interleukin-1 signaling, " Immunity, vol. 30, no. 4, pp. 576-587, 2009.
32. Y. Wang, J. Godec, K. Ben-Aissa, et al., "The transcriptionfactors T-bet and runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells, " Immunity, vol. 40, no. 3, pp. 355-366, 2014.
33. F. Zhang, G. Meng, and W. Strober, "Interactions among the transcription factors Runx1, RORt and Foxp3 regulate the differentiation of interleukin 17-producing T cells, " Nature Immunology, vol. 9, no. 11, pp. 1297-1306, 2008.
34. Y. K. Lee, H. Turner, C. L. Maynard, et al., "Late developmental plasticity in the T helper 17 lineage, " Immunity, vol. 30, no. 1, pp. 92-107, 2009.
35. R. Mukasa, A. Balasubramani, Y. K. Lee, et al., "Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage, " Immunity, vol. 32, no. 5, pp. 616-627, 2010.
36. V. Lazarevic, X. Chen, J.-H. Shim, et al., "T-bet represses TH 17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat, " Nature Immunology, vol. 12, no. 1, pp. 96-104, 2011.
37. H. G. Evans, U. Roostalu, G. J. Walter, et al., "TNF-κ blockade induces IL-10 expression in human CD4+ T cells, " Nature Communications, vol. 5, article 3199, 2014.
38. J. Xu, Y. Yang, G. Qiu, et al., "c-Maf regulates IL-10 expression during Th17 polarization, " Journal of Immunology, vol. 182, no. 10, pp. 6226-6236, 2009.
39. S. C. Liang, X.-Y. Tan, D. P. Luxenberg, et al., "Interleukin (IL) and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides, " The Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271-2279, 2006.
40. L. Cosmi, L. Maggi, V. Santarlasci, et al., "Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4, " The Journal of Allergy and Clinical Immunology, vol. 125, no. 1-3, pp. 222-230. e4, 2010.
41. K. S. Voo, Y.-H. Wang, F. R. Santori, et al., "Identification of IL-17-producing FOXP3+ regulatory T cells in humans, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4793-4798, 2009.
42. A. P. Bracken, D. Kleine-Kohlbrecher, N. Dietrich, et al., "The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells, " Genes and Development, vol. 21, no. 5, pp. 525-530, 2007.
43. S. Keerthivasan, K. Aghajani, M. Dose, et al., "β-catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells, " Science Translational Medicine, vol. 6, no. 225, Article ID 225ra28, 2014.
44. J. D. Milner, J. M. Brenchley, A. Laurence, et al., "Impaired Tβ17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, " Nature, vol. 452, no. 7188, pp. 773-776, 2008.
45. K. Chen, J. P. McAleer, Y. Lin, et al., "Th17 cells mediate cladespecific, serotype-independent mucosal immunity, " Immunity, vol. 35, no. 6, pp. 997-1009, 2011.
46. M. Lipsitch, C. G. Whitney, E. Zell, T. Kaijalainen, R. Dagan, and R. Malley, "Are anticapsular antibodies the primarymechanism of protection against invasive pneumococcal disease?" PLoS Medicine, vol. 2, no. 1, article e15, 2005.
47. A. J. van Beelen, Z. Zelinkova, E. W. Taanman-Kueter, et al., "Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells, " Immunity, vol. 27, no. 4, pp. 660-669, 2007.
48. L. Guery, J. Dubrot, C. Lippens, et al., "Ag-presenting CpGactivated pDCs prime Th17 cells that induce tumor regression, " Cancer Research, vol. 74, no. 22, pp. 6430-6440, 2014.
49. S. L. Gaffen, N. Hernand ez-Santos, and A. C. Peterson, "IL-17 signaling in host defense against Candida albicans, " Immunologic Research, vol. 50, no. 2-3, pp. 181-187, 2011.
50. H. R. Conti and S. L. Gaffen, "Host responses to Candida albicans: Th17 cells and mucosal cand idiasis, " Microbes and Infection, vol. 12, no. 7, pp. 518-527, 2010.
51. L. Lin, A. S. Ibrahim, X. Xu, et al., "Th1-Th17 cells mediate protective adaptiveimmunity against Staphylococcus aureus and Candida albicans infection in mice, " PLoS Pathogens, vol. 5, no. 12, Article ID e1000703, 2009.
52. J. Raad and J. E. Peacock Jr., "Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature, " Seminars in Arthritis and Rheumatism, vol. 34, no. 2, pp. 559-569, 2004.
53. B. G. Spratt and B. M. Greenwood, "Prevention of pneumococcal disease by vaccination: does serotype replacement matter?" The Lancet, vol. 356, no. 9237, pp. 1210-1211, 2000.
54. K. L. Moffitt, T. M. Gierahn, Y.-J. Lu, et al., "Tβ17-based vaccine design for prevention of Streptococcus pneumoniae colonization, " Cell Host and Microbe, vol. 9, no. 2, pp. 158-165, 2011.
55. Z. Zhang, T. B. Clarke, and J. N. Weiser, "Cellular effectorsmediatingTh17-dependent clearance of pneumococcal colonization in mice, "The Journal of Clinical Investigation, vol. 119, no. 7, pp. 1899-1909, 2009.
56. Y.-J. Lu, J. Gross, D. Bogaert, et al., "Interleukin-17A mediates acquired immunity to pneumococcal colonization, " PLoS Pathogens, vol. 4, no. 9, Article ID e1000159, 2008.
57. R. Malley, A. Srivastava, M. Lipsitch, et al., "Antibodyindependent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide, " Infection and Immunity, vol. 74, no. 4, pp. 2187-2195, 2006.
58. A. Lundgren, T. R. Bhuiyan, D. Novak, et al., "Characterization of Th17 responses to Streptococcus pneumoniae in humans: comparisons between adults and children in a developed and a developing country, " Vaccine, vol. 30, no. 26, pp. 3897-3907, 2012.
59. G. P. Priebe, R. L. Walsh, T. A. Cederroth, et al., "IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa, " Journal of Immunology, vol. 181, no. 7, pp. 4965-4975, 2008.
60. W. Wu, J. Huang, B. Duan, et al., "Th17-stimulating protein vaccines confer protection against Pseudomonas aeruginosa pneumonia, " American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 5, pp. 420-427, 2012.
61. S. C. Higgins, A. G. Jarnicki, E. C. Lavelle, and K. H. G. Mills, "TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells, " Journal of Immunology, vol. 177, no. 11, pp. 7980-7989, 2006.
62. D. C. Newcomb, M. G. Boswell, W. Zhou, et al., "Human TH17 cells express a functional IL-13 receptor and IL-13 attenuates IL-17A production, " The Journal of Allergy and Clinical Immunology, vol. 127, no. 4, pp. 1006-1013, 2011.
63. T. E. Faber, H. Groen, M. Welfing, K. J. G. Jansen, and L. J. Bont, "Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis, " Journal of Medical Virology, vol. 84, no. 7, pp. 1084-1088, 2012.
64. C. Schnoeller, X. Roux, D. Sawant, et al., "Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism, " American Journal of Respiratory and Critical CareMedicine, vol. 189, no. 2, pp. 194-202, 2014.
65. M. Numasaki, J. I. Fukushi, M. Ono, et al., "Interleukin-17 promotes angiogenesis and tumor growth, " Blood, vol. 101, no. 7, pp. 2620-2627, 2003.
66. I. Kryczek, M. Banerjee, P. Cheng, et al., "Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments, " Blood, vol. 114, no. 6, pp. 1141-1149, 2009.
67. J.-P. Zhang, J. Yan, J. Xu, et al., "Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients, " Journal of Hepatology, vol. 50, no. 5, pp. 980-989, 2009.
68. S. I. Grivennikov, K. Wang, D. Mucida, et al., "Adenomalinked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth, " Nature, vol. 491, no. 7423, pp. 254-258, 2012.
69. E. Punkenburg, T. Vogler, M. Buttner, et al., "Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer, " Gut, 2015.
70. S. Wu, K.-J. Rhee, E. Albesiano, et al., "A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, " Nature Medicine, vol. 15, no. 9, pp. 1016-1022, 2009.
71. K. Wang, M. Kim, G. Di Caro, et al., "Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis, " Immunity, vol. 41, no. 6, pp. 1052-1063, 2014.
72. D. He, H. Li, N. Yusuf, et al., "IL-17 mediated inflammation promotes tumor growth and progression in the skin, " PLoS ONE, vol. 7, no. 2, Article ID e32126, 2012.
73. X. Su, J. Ye, E. C. Hsueh, Y. Zhang, D. F. Hoft, and G. Peng, "Tumor microenvironments direct the recruitment and expansion of humanTh17 cells, " Journal of Immunology, vol. 184, no. 3, pp. 1630-1641, 2010.
74. N. Martin-Orozco and C. Dong, "The IL-17/IL-23 axis of inflammation in cancer: friend or foe?" Current Opinion in Investigational Drugs, vol. 10, no. 6, pp. 543-549, 2009.
75. F. Chalmin, G. Mignot, M. Bruchard, et al., "Stat3 and Gfi transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression, " Immunity, vol. 36, no. 3, pp. 362-373, 2012.
76. B. Bierie and H. L. Moses, "Transforming growth factor beta (TGF-β) and inflammation in cancer, " Cytokine & Growth Factor Reviews, vol. 21, no. 1, pp. 49-59, 2010.
77. J. Liu, Y. Duan, X. Cheng, et al., "IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma, " Biochemical and Biophysical Research Communications, vol. 407, no. 2, pp. 348-354, 2011.
78. L. Wang, T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu, "IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway, " The Journal of Experimental Medicine, vol. 206, no. 7, pp. 1457-1464, 2009.
79. C. M. Paulos, C. Carpenito, G. Plesa, et al., "The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells, " Science Translational Medicine, vol. 2, no. 55, Article ID 55ra78, 2010.
80. J. R. Huh, M. W. L. Leung, P. Huang, et al., "Digoxin and its derivatives suppress T H17 cell differentiation by antagonizing ROR3t activity, " Nature, vol. 472, no. 7344, pp. 486-490, 2011.
81. S. Xiao, N. Yosef, J. Yang, et al., "Small-molecule RORgammat antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms, " Immunity, vol. 40, no. 4, pp. 477-489, 2014.
82. L. A. Solt, N. Kumar, P. Nuhant, et al., "Suppression of T17 differentiation and autoimmunity by a synthetic ROR ligand, " Nature, vol. 472, no. 7344, pp. 491-494, 2011.
83. T. Xu, X. Wang, B. Zhong, R. I. Nurieva, S. Ding, and C. Dong, "Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORt protein, " The Journal of Biological Chemistry, vol. 286, no. 26, pp. 22707-22710, 2011.
84. O. Frey, J. Meisel, A. Hutloff, et al., "Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis, " Annals of the Rheumatic Diseases, vol. 69, no. 8, pp. 1495-1501, 2010.
85. H. Kebir, K. Kreymborg, I. Ifergan, et al., "Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation, " Nature Medicine, vol. 13, no. 10, pp. 1173-1175, 2007.
86. P. P. Ahern, C. Schiering, S. Buonocore, et al., "Interleukin drives intestinal inflammation through direct activity on T cells, " Immunity, vol. 33, no. 2, pp. 279-288, 2010.
87. F. Annunziato, L. Cosmi, V. Santarlasci, et al., "Phenotypic and functional features of human Th17 cells, " The Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849-1861, 2007.
88. K. Nistala, S. Adams, H. Cambrook, et al., "Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14751-14756, 2010.
89. D. Bending, H. de la Pena, M. Veldhoen, et al., "Highly purified Th17 cells from BDC2. 5NOD mice convert into Th1-like cells in NOD/SCID recipient mice, "The Journal of Clinical Investigation, vol. 119, no. 3, pp. 565-572, 2009.
90. H. Kebir, I. Ifergan, J. I. Alvarez, et al., "Preferential recruitment of interferon-β-expressing TH17 cells in multiple sclerosis, " Annals of Neurology, vol. 66, no. 3, pp. 390-402, 2009.
91. C.-Q. Chu, S. Wittmer, and D. K. Dalton, "Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis, " The Journal of Experimental Medicine, vol. 192, no. 1, pp. 123-128, 2000.
92. S. Haak, A. L. Croxford, K. Kreymborg, et al., "IL-17Aand IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice, "The Journal of Clinical Investigation, vol. 119, no. 1, pp. 61-69, 2009.
93. L. Codarri, G. Gyulveszii, V. Tosevski, et al., "ROR3t drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation, " Nature Immunology, vol. 12, no. 6, pp. 560-567, 2011.
94. M. El-Behi, B. Ciric, H. Dai, et al., "The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF, " Nature Immunology, vol. 12, no. 6, pp. 568-575, 2011.
95. W. Sheng, F. Yang, Y. Zhou, et al., "STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation, " Cell Research, vol. 24, no. 12, pp. 1387-1402, 2014.
96. R. Noster, R. Riedel, M. Mashreghi, et al., "IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells, " Science Translational Medicine, vol. 6, no. 241, Article ID 241ra80, 2014.
97. Y. Kondo, M. Iizuka, E. Wakamatsu, et al., "Overexpression of T-bet gene regulates murine autoimmune arthritis, " Arthritis & Rheumatism, vol. 64, no. 1, pp. 162-172, 2012.
98. S. Alzabin, S. M. Abraham, T. E. Taher, et al., "Incomplete response of inflammatory arthritis to TNFalpha blockade is associated with the Th17 pathway, " Annals of the Rheumatic Diseases, vol. 71, no. 10, pp. 1741-1748, 2012.
99. H. Takayanagi, K. Ogasawara, S. Hida, et al., "T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-β, " Nature, vol. 408, no. 6812, pp. 600-605, 2000.
100. Y. Okada, D. Wu, G. Trynka, et al., "Genetics of rheumatoid arthritis contributes to biology and drug discovery, " Nature, vol. 506, no. 7488, pp. 376-381, 2014.
101. T. S. Plantinga, J. Fransen, N. Takahashi, et al., "Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis, " Arthritis Research & Therapy, vol. 12, no. 1, article R26, 2010.
102. S. Bishu, E. W. Su, E. R. Wilkerson, et al., "Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses, " Arthritis Research and Therapy, vol. 16, article R50, 2014.